BMC biology · 2025
An interpretable geometric graph neural network for enhancing the generalizability of drug-target interaction prediction.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiong An, Luo Zhenjie, Xia Yan, Zou Quan, Wei Leyi, Zhang Zilong, Wang Tao, Wei Lesong, Cui Feifei
Аннотация
BACKGROUND: Accurate prediction of drug-target interactions (DTIs) is essential for advancing drug discovery. Although numerous computational methods have been proposed, many exhibit limited generalization, particularly when dealing with unseen drugs or targets.
RESULTS: To address this challenge, we introduce GPS-DTI, a deep learning framework designed to capture both local and global features of drugs and proteins, thereby enhancing predictive robustness. Specifically, GPS-DTI employs a graph isomorphism network with edge features (GINE)-based graph neural network, combined with a multi-head attention mechanism (MHAM), to effectively model the structural characteristics of drug molecules. For proteins, representations are derived from the pre-trained Evolutionary Scale Model (ESM-2) model and further refined through convolutional neural networks (CNNs), yielding rich feature embeddings. A cross-attention module integrates drug and protein features, uncovering biologically meaningful interactions and improving model interpretability.
CONCLUSIONS: Comprehensive benchmarking across in-domain and cross-domain DTI prediction tasks demonstrates that GPS-DTI outperforms existing methods, underscoring its strong generalization capability. Notably, the model achieves state-of-the-art performance on drug-target affinity (DTA) tasks and shows robust adaptability when evaluated on an independent Coronavirus Disease 2019 (COVID-19)-related test set. Furthermore, visualization of cross-attention maps offers interpretable insights into key molecular interactions, highlighting the potential of GPS-DTI in real-world drug discovery applications.
RESULTS: To address this challenge, we introduce GPS-DTI, a deep learning framework designed to capture both local and global features of drugs and proteins, thereby enhancing predictive robustness. Specifically, GPS-DTI employs a graph isomorphism network with edge features (GINE)-based graph neural network, combined with a multi-head attention mechanism (MHAM), to effectively model the structural characteristics of drug molecules. For proteins, representations are derived from the pre-trained Evolutionary Scale Model (ESM-2) model and further refined through convolutional neural networks (CNNs), yielding rich feature embeddings. A cross-attention module integrates drug and protein features, uncovering biologically meaningful interactions and improving model interpretability.
CONCLUSIONS: Comprehensive benchmarking across in-domain and cross-domain DTI prediction tasks demonstrates that GPS-DTI outperforms existing methods, underscoring its strong generalization capability. Notably, the model achieves state-of-the-art performance on drug-target affinity (DTA) tasks and shows robust adaptability when evaluated on an independent Coronavirus Disease 2019 (COVID-19)-related test set. Furthermore, visualization of cross-attention maps offers interpretable insights into key molecular interactions, highlighting the potential of GPS-DTI in real-world drug discovery applications.